BMS 303141
-
BMS 303141
structure -
-
CAS No:
943962-47-8
-
Formula:
C19H15Cl2NO4S
-
Chemical Name:
BMS 303141
-
Synonyms:
BMS 303141;BMS30314;3,5-dichloro-2-hydroxy-N-(4-Methoxybiphenyl-3-yl)benzenesulfonaMide;3,5-Dichloro-2-hydroxy-N-(4-methoxy[1,1'-biphenyl]-3-yl)benzenesulfonamide;3,5-Dichloro-2-hydroxy-N-(4-methoxy[1,1'-biphenyl]-3-yl)-benzenesulfonamide BMS 303141;BMS 303141, >=98%
- Categories:
-
CAS No:
Description
3,5-dichloro-2-hydroxy-N-(2-methoxy-5-phenylphenyl)benzenesulfonamide is a member of biphenyls.
Characteristics
84
5.5
white to beige
1.462±0.06 g/cm3(Predicted)
594.9±60.0°C at 760 mmHg
DMSO: soluble 20mg/mL, clear
2-8°C
Computed Properties
Molecular Weight:424.3
XLogP3:5.5
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:5
Exact Mass:423.0098845
Monoisotopic Mass:423.0098845
Topological Polar Surface Area:84
Heavy Atom Count:27
Complexity:579
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of BMS 303141
-
CN
1 YR
Business licensedTrader Supplier of 3-(1-Naphthoyl)indoleInquiryUnit Price: $1500-1800 /G FOBCAS No.: 943962-47-8Grade: Reagent GradeContent: 98% -
CN
1 YR
Business licensed Certified factoryManufactory Supplier of SR17018
Latest News on BMS 303141
- BMS Over $900 Million to Help Develop Potential 'Best-in-class' SHP2 Inhibitors
- AbbVie's blockbuster product for atopic dermatitis, Upadacitinib, has been approved for marketing in the EU and Japan
- Designing peptide inhibitors for possible COVID-19 treatments
- Chinese scientists discover the inhibitors of SARS-CoV-2
Learn More Other Chemicals
-
BMS 582949
623152-17-0
-
BMS 599626-d4
1330172-72-9
-
BMS 182264
127749-54-6
-
BMS 626529 Formula
701213-36-7
-
BMS 188745 Potassium Salt Formula
157126-15-3
-
BMS 833923 Formula
1059734-66-5
-
BMS 566394 Structure
503166-51-6
-
BMS 204352 Structure
187523-35-9
-
What is Dabrafenib
1195765-45-7
-
What is BOC-VAL-VAL-OH
69209-73-0